Objectives:

1. Identify regulatory and administrative challenges of clinical trials, and discuss related activities, tools, and resources available through ASCO.
2. Review ASCO recommendations regarding clinical trial pre-selection and adverse/serious adverse event documentation and reporting. 

Attendance is FREE and open to anyone with an interest and/or stake in cancer clinical trials, though this session will be especially interesting for individuals dealing with regulatory and administrative requirements of administering clinical trials. 

Note: This event has been cancelled.